Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Notfall & Rettungsmedizin|August 25, 2020
[Strategy for university emergency room management at the beginning of an epidemic using COVID-19 as an example]Michael Dommasch, Friedemann Gebhardt, Ulrike Protzer, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 30, 2013
Association of myeloperoxidase with ovarian cancerDan Cacsire Castillo-Tong, Dietmar Pils, Georg Heinze, et al.
Cancer Science|April 14, 2012
Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD ConsortiumDietmar Pils, Gudrun Hager, Dan Tong, et al.
Oncotarget|February 6, 2014
Role of miR-34a as a suppressor of L1CAM in endometrial carcinomaUwe Schirmer, Kai Doberstein, Anne-Kathleen Rupp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivoNicole Concin, Gerda Hofstetter, Astrid Berger, et al.
Oncology Reports|December 3, 2011
MDM2 SNP309 modifies the prognostic significance of the p53 mutational status in patients with ovarian cancerGerda Hofstetter, Astrid Berger, Eva-Maria Bauer, et al.
BMC Cancer|April 5, 2013
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortiumDietmar Pils, Dan Tong, Gudrun Hager, et al.
International Journal of Cancer|April 27, 2024
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortiumEva Obermayr, Thomas Mohr, Eva Schuster, et al.
BMC Cancer|September 19, 2013
Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortiumAnna Bachmayr-Heyda, Stefanie Aust, Georg Heinze, et al.
Oncogene|July 4, 2023
Amyloid-like p53 as prognostic biomarker in serous ovarian cancer-a study of the OVCAD consortiumNicole Heinzl, Elisabeth Maritschnegg, Katarzyna Koziel, et al.
Pageof 4